Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung

Background. The relative incidence of adenocarcinoma of the lung is increasing and some patients with lung carcinoma, detected at an early stage, still develop recurrent disease despite complete resection of the tumor. Recently, neuroendocrine differentiation in large cell carcinoma of the lung has...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Annals of thoracic surgery 2002-06, Vol.73 (6), p.1732-1735
Hauptverfasser: Hiroshima, Kenzo, Iyoda, Akira, Shibuya, Kiyoshi, Toyozaki, Tetsuya, Haga, Yukiko, Fujisawa, Takehiko, Ohwada, Hidemi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1735
container_issue 6
container_start_page 1732
container_title The Annals of thoracic surgery
container_volume 73
creator Hiroshima, Kenzo
Iyoda, Akira
Shibuya, Kiyoshi
Toyozaki, Tetsuya
Haga, Yukiko
Fujisawa, Takehiko
Ohwada, Hidemi
description Background. The relative incidence of adenocarcinoma of the lung is increasing and some patients with lung carcinoma, detected at an early stage, still develop recurrent disease despite complete resection of the tumor. Recently, neuroendocrine differentiation in large cell carcinoma of the lung has been reported to be of prognostic significance. Therefore, we have evaluated the prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Methods. A total of 90 resected specimens of adenocarcinoma of the lung measuring 3 cm or less (T1 N0 M0 or T2 N0 M0) were reviewed histologically and immunohistochemical staining was performed to determine the degree of neuroendocrine differentiation. Results. Seven adenocarcinomas exhibited neuroendocrine differentiation in 10% or more of tumor cells. The disease-free survival rate for these patients was significantly lower than that of patients with tumors exhibiting neuroendocrine differentiation in less than 10% of tumor cells or with absent neuroendocrine differentiation ( p < 0.0005). Other conventional pathologic factors such as vascular invasion ( p < 0.0005), lymphatic invasion ( p < 0.05), and pleural involvement ( p < 0.05) were also of prognostic significance. In multivariate analysis, the presence of 10% or more neuroendocrine marker-positive tumor cells, vascular invasion, and lymphatic invasion were found to be significantly adverse prognostic factors ( p = 0.0162, p = 0.0111, and p = 0.0173, respectively). Conclusions. Neuroendocrine differentiation of tumor cells is a prognostic factor in lung adenocarcinoma. It is suggested that the identification of neuroendocrine differentiation as well as vascular invasion by tumor in small peripheral adenocarcinoma of the lung may predict the prognosis of these patients.
doi_str_mv 10.1016/S0003-4975(02)03504-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71841448</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000349750203504X</els_id><sourcerecordid>71841448</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-2a5974a77809b71fd592a617acea0939f4a6bc82879d62f62be625c078f4f0c63</originalsourceid><addsrcrecordid>eNqFkF1LHDEUhoNU6mr7EyxzU7EXo0kmH5OrImJbQbBgS70L2czJ9pTZxCYzgv--WXepl16FkOc9581DyDGjZ4wydX5HKe1aYbQ8pfwT7SQV7f0eWTApeau4NG_I4j9yQA5L-VOvvD6_JQeMU91rxRbk1_ecVjGVCX1TcBUxoHfRQ5NCE2HOCeKQfMYIzYAhQIY4oZswxQZj4waIybvsMaa122Sm39CMc1y9I_vBjQXe784j8vPL1Y_Lb-3N7dfry4ub1ktBp5Y7abRwWvfULDULgzTcKaadB0dNZ4Jwaul73mszKB4UX0L9m6_tgwjUq-6InGznPuT0d4Yy2TUWD-PoIqS5WM16wYToKyi3oM-plAzBPmRcu_xkGbUbo_bZqN3ospTbZ6P2vuY-7BbMyzUML6mdwgp83AGueDeGXPVheeE6TQ1TmwKftxxUHY8I2RaPUFUPmMFPdkj4SpV_OA2TkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71841448</pqid></control><display><type>article</type><title>Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via ScienceDirect (Elsevier)</source><source>Alma/SFX Local Collection</source><creator>Hiroshima, Kenzo ; Iyoda, Akira ; Shibuya, Kiyoshi ; Toyozaki, Tetsuya ; Haga, Yukiko ; Fujisawa, Takehiko ; Ohwada, Hidemi</creator><creatorcontrib>Hiroshima, Kenzo ; Iyoda, Akira ; Shibuya, Kiyoshi ; Toyozaki, Tetsuya ; Haga, Yukiko ; Fujisawa, Takehiko ; Ohwada, Hidemi</creatorcontrib><description>Background. The relative incidence of adenocarcinoma of the lung is increasing and some patients with lung carcinoma, detected at an early stage, still develop recurrent disease despite complete resection of the tumor. Recently, neuroendocrine differentiation in large cell carcinoma of the lung has been reported to be of prognostic significance. Therefore, we have evaluated the prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Methods. A total of 90 resected specimens of adenocarcinoma of the lung measuring 3 cm or less (T1 N0 M0 or T2 N0 M0) were reviewed histologically and immunohistochemical staining was performed to determine the degree of neuroendocrine differentiation. Results. Seven adenocarcinomas exhibited neuroendocrine differentiation in 10% or more of tumor cells. The disease-free survival rate for these patients was significantly lower than that of patients with tumors exhibiting neuroendocrine differentiation in less than 10% of tumor cells or with absent neuroendocrine differentiation ( p &lt; 0.0005). Other conventional pathologic factors such as vascular invasion ( p &lt; 0.0005), lymphatic invasion ( p &lt; 0.05), and pleural involvement ( p &lt; 0.05) were also of prognostic significance. In multivariate analysis, the presence of 10% or more neuroendocrine marker-positive tumor cells, vascular invasion, and lymphatic invasion were found to be significantly adverse prognostic factors ( p = 0.0162, p = 0.0111, and p = 0.0173, respectively). Conclusions. Neuroendocrine differentiation of tumor cells is a prognostic factor in lung adenocarcinoma. It is suggested that the identification of neuroendocrine differentiation as well as vascular invasion by tumor in small peripheral adenocarcinoma of the lung may predict the prognosis of these patients.</description><identifier>ISSN: 0003-4975</identifier><identifier>EISSN: 1552-6259</identifier><identifier>DOI: 10.1016/S0003-4975(02)03504-X</identifier><identifier>PMID: 12078761</identifier><identifier>CODEN: ATHSAK</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adenocarcinoma - chemistry ; Adenocarcinoma - mortality ; Adenocarcinoma - pathology ; Aged ; Biological and medical sciences ; Biomarkers, Tumor - analysis ; Female ; Humans ; Incidence ; Lung Neoplasms - chemistry ; Lung Neoplasms - mortality ; Lung Neoplasms - pathology ; Male ; Medical sciences ; Middle Aged ; Multivariate Analysis ; Neurosecretion ; Pneumology ; Prognosis ; Survival Rate ; Tumors of the respiratory system and mediastinum</subject><ispartof>The Annals of thoracic surgery, 2002-06, Vol.73 (6), p.1732-1735</ispartof><rights>2002 The Society of Thoracic Surgeons</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-2a5974a77809b71fd592a617acea0939f4a6bc82879d62f62be625c078f4f0c63</citedby><cites>FETCH-LOGICAL-c540t-2a5974a77809b71fd592a617acea0939f4a6bc82879d62f62be625c078f4f0c63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0003-4975(02)03504-X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13709168$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12078761$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hiroshima, Kenzo</creatorcontrib><creatorcontrib>Iyoda, Akira</creatorcontrib><creatorcontrib>Shibuya, Kiyoshi</creatorcontrib><creatorcontrib>Toyozaki, Tetsuya</creatorcontrib><creatorcontrib>Haga, Yukiko</creatorcontrib><creatorcontrib>Fujisawa, Takehiko</creatorcontrib><creatorcontrib>Ohwada, Hidemi</creatorcontrib><title>Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung</title><title>The Annals of thoracic surgery</title><addtitle>Ann Thorac Surg</addtitle><description>Background. The relative incidence of adenocarcinoma of the lung is increasing and some patients with lung carcinoma, detected at an early stage, still develop recurrent disease despite complete resection of the tumor. Recently, neuroendocrine differentiation in large cell carcinoma of the lung has been reported to be of prognostic significance. Therefore, we have evaluated the prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Methods. A total of 90 resected specimens of adenocarcinoma of the lung measuring 3 cm or less (T1 N0 M0 or T2 N0 M0) were reviewed histologically and immunohistochemical staining was performed to determine the degree of neuroendocrine differentiation. Results. Seven adenocarcinomas exhibited neuroendocrine differentiation in 10% or more of tumor cells. The disease-free survival rate for these patients was significantly lower than that of patients with tumors exhibiting neuroendocrine differentiation in less than 10% of tumor cells or with absent neuroendocrine differentiation ( p &lt; 0.0005). Other conventional pathologic factors such as vascular invasion ( p &lt; 0.0005), lymphatic invasion ( p &lt; 0.05), and pleural involvement ( p &lt; 0.05) were also of prognostic significance. In multivariate analysis, the presence of 10% or more neuroendocrine marker-positive tumor cells, vascular invasion, and lymphatic invasion were found to be significantly adverse prognostic factors ( p = 0.0162, p = 0.0111, and p = 0.0173, respectively). Conclusions. Neuroendocrine differentiation of tumor cells is a prognostic factor in lung adenocarcinoma. It is suggested that the identification of neuroendocrine differentiation as well as vascular invasion by tumor in small peripheral adenocarcinoma of the lung may predict the prognosis of these patients.</description><subject>Adenocarcinoma - chemistry</subject><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - pathology</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Lung Neoplasms - chemistry</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Neurosecretion</subject><subject>Pneumology</subject><subject>Prognosis</subject><subject>Survival Rate</subject><subject>Tumors of the respiratory system and mediastinum</subject><issn>0003-4975</issn><issn>1552-6259</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LHDEUhoNU6mr7EyxzU7EXo0kmH5OrImJbQbBgS70L2czJ9pTZxCYzgv--WXepl16FkOc9581DyDGjZ4wydX5HKe1aYbQ8pfwT7SQV7f0eWTApeau4NG_I4j9yQA5L-VOvvD6_JQeMU91rxRbk1_ecVjGVCX1TcBUxoHfRQ5NCE2HOCeKQfMYIzYAhQIY4oZswxQZj4waIybvsMaa122Sm39CMc1y9I_vBjQXe784j8vPL1Y_Lb-3N7dfry4ub1ktBp5Y7abRwWvfULDULgzTcKaadB0dNZ4Jwaul73mszKB4UX0L9m6_tgwjUq-6InGznPuT0d4Yy2TUWD-PoIqS5WM16wYToKyi3oM-plAzBPmRcu_xkGbUbo_bZqN3ospTbZ6P2vuY-7BbMyzUML6mdwgp83AGueDeGXPVheeE6TQ1TmwKftxxUHY8I2RaPUFUPmMFPdkj4SpV_OA2TkA</recordid><startdate>20020601</startdate><enddate>20020601</enddate><creator>Hiroshima, Kenzo</creator><creator>Iyoda, Akira</creator><creator>Shibuya, Kiyoshi</creator><creator>Toyozaki, Tetsuya</creator><creator>Haga, Yukiko</creator><creator>Fujisawa, Takehiko</creator><creator>Ohwada, Hidemi</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020601</creationdate><title>Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung</title><author>Hiroshima, Kenzo ; Iyoda, Akira ; Shibuya, Kiyoshi ; Toyozaki, Tetsuya ; Haga, Yukiko ; Fujisawa, Takehiko ; Ohwada, Hidemi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-2a5974a77809b71fd592a617acea0939f4a6bc82879d62f62be625c078f4f0c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adenocarcinoma - chemistry</topic><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - pathology</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Lung Neoplasms - chemistry</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Neurosecretion</topic><topic>Pneumology</topic><topic>Prognosis</topic><topic>Survival Rate</topic><topic>Tumors of the respiratory system and mediastinum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hiroshima, Kenzo</creatorcontrib><creatorcontrib>Iyoda, Akira</creatorcontrib><creatorcontrib>Shibuya, Kiyoshi</creatorcontrib><creatorcontrib>Toyozaki, Tetsuya</creatorcontrib><creatorcontrib>Haga, Yukiko</creatorcontrib><creatorcontrib>Fujisawa, Takehiko</creatorcontrib><creatorcontrib>Ohwada, Hidemi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Annals of thoracic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hiroshima, Kenzo</au><au>Iyoda, Akira</au><au>Shibuya, Kiyoshi</au><au>Toyozaki, Tetsuya</au><au>Haga, Yukiko</au><au>Fujisawa, Takehiko</au><au>Ohwada, Hidemi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung</atitle><jtitle>The Annals of thoracic surgery</jtitle><addtitle>Ann Thorac Surg</addtitle><date>2002-06-01</date><risdate>2002</risdate><volume>73</volume><issue>6</issue><spage>1732</spage><epage>1735</epage><pages>1732-1735</pages><issn>0003-4975</issn><eissn>1552-6259</eissn><coden>ATHSAK</coden><abstract>Background. The relative incidence of adenocarcinoma of the lung is increasing and some patients with lung carcinoma, detected at an early stage, still develop recurrent disease despite complete resection of the tumor. Recently, neuroendocrine differentiation in large cell carcinoma of the lung has been reported to be of prognostic significance. Therefore, we have evaluated the prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung. Methods. A total of 90 resected specimens of adenocarcinoma of the lung measuring 3 cm or less (T1 N0 M0 or T2 N0 M0) were reviewed histologically and immunohistochemical staining was performed to determine the degree of neuroendocrine differentiation. Results. Seven adenocarcinomas exhibited neuroendocrine differentiation in 10% or more of tumor cells. The disease-free survival rate for these patients was significantly lower than that of patients with tumors exhibiting neuroendocrine differentiation in less than 10% of tumor cells or with absent neuroendocrine differentiation ( p &lt; 0.0005). Other conventional pathologic factors such as vascular invasion ( p &lt; 0.0005), lymphatic invasion ( p &lt; 0.05), and pleural involvement ( p &lt; 0.05) were also of prognostic significance. In multivariate analysis, the presence of 10% or more neuroendocrine marker-positive tumor cells, vascular invasion, and lymphatic invasion were found to be significantly adverse prognostic factors ( p = 0.0162, p = 0.0111, and p = 0.0173, respectively). Conclusions. Neuroendocrine differentiation of tumor cells is a prognostic factor in lung adenocarcinoma. It is suggested that the identification of neuroendocrine differentiation as well as vascular invasion by tumor in small peripheral adenocarcinoma of the lung may predict the prognosis of these patients.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>12078761</pmid><doi>10.1016/S0003-4975(02)03504-X</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-4975
ispartof The Annals of thoracic surgery, 2002-06, Vol.73 (6), p.1732-1735
issn 0003-4975
1552-6259
language eng
recordid cdi_proquest_miscellaneous_71841448
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via ScienceDirect (Elsevier); Alma/SFX Local Collection
subjects Adenocarcinoma - chemistry
Adenocarcinoma - mortality
Adenocarcinoma - pathology
Aged
Biological and medical sciences
Biomarkers, Tumor - analysis
Female
Humans
Incidence
Lung Neoplasms - chemistry
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Male
Medical sciences
Middle Aged
Multivariate Analysis
Neurosecretion
Pneumology
Prognosis
Survival Rate
Tumors of the respiratory system and mediastinum
title Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A36%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20significance%20of%20neuroendocrine%20differentiation%20in%20adenocarcinoma%20of%20the%20lung&rft.jtitle=The%20Annals%20of%20thoracic%20surgery&rft.au=Hiroshima,%20Kenzo&rft.date=2002-06-01&rft.volume=73&rft.issue=6&rft.spage=1732&rft.epage=1735&rft.pages=1732-1735&rft.issn=0003-4975&rft.eissn=1552-6259&rft.coden=ATHSAK&rft_id=info:doi/10.1016/S0003-4975(02)03504-X&rft_dat=%3Cproquest_cross%3E71841448%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71841448&rft_id=info:pmid/12078761&rft_els_id=S000349750203504X&rfr_iscdi=true